KR20120038611A - Pharmaceutical composition for preventing or treating liver cancer comprising herbal extracts - Google Patents

Abstract

PURPOSE: A pharmaceutical composition containing crude drug extract is provided to ensure high antioxidation and to anticancer effect. CONSTITUTION: A pharmaceutical composition for preventing or treating liver cancer contains extract of Ginseng radix, Lycium chinense Mill., Cornaceae, Schisandraceae, Cuscuta japonica Choisy, Curcuma aromatica Salisb., and Angelica gigas Nakai as an active ingredient. The extract is prepared using water, low alcohol of 1-4 carbon atoms, acetone, ether, ethyl acetate, butyl acetate, chloroform, methylene chloride, hexane, 1,3-butylene glycol, or mixture thereof. A composition for functional health foods for preventing or treating liver cancer contains the extract as an active ingredient.

Description

Pharmaceutical composition for preventing or treating liver cancer comprising herbal extracts}

The present invention relates to a pharmaceutical composition for preventing or treating liver cancer, including a herbal extract, and more particularly, extracts of red ginseng, wolfberry, cornus oil, Schisandra chinensis, Bokbunja, Tosa, turmeric and Angelica as active ingredients, high antioxidant In particular, the present invention relates to a pharmaceutical composition for preventing or treating liver cancer, which has activity and excellent anti-cancer effect against liver cancer.

Liver cancer is one of the most deadly cancers in the world, and it is a serious problem because it is particularly common in Asian countries. Solid carcinoma, which accounts for more than 90% of liver cancers, is difficult to treat and has a very poor prognosis. Most of the cases are due to the fact that there is no symptom at the beginning, and progressed beyond treatment at the time of discovery, and about 80% of patients with liver cancer. This is because most people start with cirrhosis and die from complications. The most important method in the treatment of liver cancer is surgical removal. If the cancer cannot be removed by surgery, liver transplantation, hepatic artery embolization, percutaneous ethanol injection, and immunochemotherapy are used. Liver resection is the treatment of relatively early patients without metastases among liver cancer patients. Currently, about 20% of all liver cancer patients are treated by liver resection, but long-term survival rate is high even in liver cancer patients who have undergone liver resection. I'm not. In particular, many patients die at 30-40% survival rate within 5 years after surgery. In addition, surgical therapy may cause side effects such as bleeding and infection, and hypersensitivity reactions to immunosuppressive agents, chills and fever, nausea and vomiting, general weakness, anorexia, headache, anemia, and leukopenia during immunochemotherapy This can happen.

Therefore, many studies have been conducted to find natural products exhibiting anti-cancer effects against liver cancer with less toxicity and side effects, and in particular, researches on the development of anti-cancer drugs and anti-cancer treatment aids using herbal medicines that are relatively safe for human body are being actively conducted. .

On the other hand, there are carbontetrachoride (CCl4), chloroform, phophorus, DEN (diethylnitrosamine), etc., which cause oxidative stress and cause organ damage. In particular, DEN (diethylnitrosamine) is a genotoxic carcinogen known to cause liver cancer, colon cancer and renal cell carcinoma.

The present inventors found that the herbal extracts of red ginseng, goji berry, cornus oil, Schisandra chinensis, Bokbunja, Tosa, turmeric, and Angelica were effective against liver cancer-induced stimulation by continuous oral administration of DEN. The present invention has been completed by discovering.

An object of the present invention is to provide a pharmaceutical composition for preventing or treating liver cancer comprising red ginseng, goji berry, cornus, schisandra chinensis, bokbunja, earth and sand, turmeric and Angelica extract as an active ingredient.

Another object of the present invention to provide a method for preventing or treating liver cancer comprising administering the pharmaceutical composition for preventing or treating liver cancer.

Another object of the present invention is to provide a health functional food composition for preventing or improving liver cancer comprising red ginseng, goji berry, cornus, schisandra chinensis, bokbunja, earth and sand, turmeric, and Angelica extract as an active ingredient.

In one embodiment, the present invention relates to a pharmaceutical composition for preventing or treating liver cancer comprising red ginseng, goji berry, cornus oil, schisandra chinensis, bokbunja, earth and sand, turmeric, and Angelica extract as an active ingredient.

The pharmaceutical composition of the present invention is characterized by having an antioxidant activity.

The pharmaceutical composition of the present invention may be for the production of anticancer resonance stage.

In the present invention, the extract may be extracted with water, lower alcohol having 1 to 4 carbon atoms, acetone, ether, ethyl acetate, butyl acetate, chloroform, methylene chloride, hexane, 1,3 butylene glycol or a mixed solvent thereof. .

The composition of the present invention is Gobon, Cheonma, Shiho, Doin, Gyeji, Rhubarb, Licorice, Cheongung, Dermis, Taxa, Huangyan, Golden, Fuling, Peony, Baekchul, Yellow white, Gardenia, Banja, Jaguk, Jisil, Ginseng, Macmundong, Wonji, Seokchangpo, Creation, Gamkook, Windproof, Ginger, Forget-me-not, Contrast, Dansam, Peel, Peel, Chihwang, Mint, Pomegranate, Spirit, Shouo, Guja, Cassia, Poisonous, Tochung, Baekhwasaengcho, Three hundred seconds, Injin, Jimo, Safflower, Astragalus It may further include one or more extracts of herbal medicines, such as calendula, ginkgo biloba, yellow flower, lotus root, keel, phalanges, hyssop, sorghum, black sesame seed, white porcelain, malt, pageokcheon and sea song.

In another aspect, the present invention relates to a method for preventing or treating liver cancer comprising administering the pharmaceutical composition for preventing or treating liver cancer.

In another aspect, the present invention relates to a health functional food composition for preventing or improving liver cancer comprising red ginseng, goji berry, cornus oil, Schisandra chinensis, bokbunja, earth and sand, turmeric, and Angelica extract as active ingredients.

The pharmaceutical composition for liver cancer prevention or treatment comprising red ginseng, goji berry, cornus milk, Schisandra chinensis, bokbunja, earthworm, turmeric, and Angelica extract as an active ingredient has antioxidant activity and hepatocellular damage due to oxidative stress Since the anti-cancer effect through inhibition, it can be usefully used in the manufacture of pharmaceutical preparations and health functional food for the treatment or prevention of liver cancer.

In addition, the pharmaceutical composition is excellent in the texture when processed in the form of pills can be used for the production of anti-cancer diagnostics for the treatment or prevention of liver cancer.

Figure 1 shows a series of procedures for obtaining methanol, hexane, chloroform, ethyl acetate, butanol and aqueous layer fraction of the herbal extract according to the present invention.
Figure 2 is a graph measuring the ABST radical scavenging ability of the herbal extract according to the present invention.
Figure 3 is a graph measuring the measurement of SOD (Superoxide dismutase) -like activity of the herbal extract according to the present invention.
Figure 4 is a result of examining the form of liver tissue after administration of the herbal extract according to the present invention to the liver cancer induced rats.
5 is a graph evaluating the effect of the herbal extracts according to the present invention on LDH activity of rats induced liver cancer.
6 is a graph evaluating the effect of the herbal extract according to the present invention on the AST activity of rats induced liver cancer.
Figure 7 is a graph evaluating the effect of the herbal extract according to the present invention on ALT activity of liver cancer induced rats.
8 is a graph evaluating the effect of the herbal extracts according to the present invention on ALP activity of liver cancer induced rats.

The pharmaceutical composition for preventing or treating liver cancer of the present invention is characterized in that it comprises an extract of red ginseng, wolfberry, cornus, Schisandra chinensis, bokbunja, earth and sand, turmeric and Angelica as an active ingredient.

Hereinafter, the configuration of the present invention in more detail.

The red ginseng included in the composition of the present invention ( Ginseng radix ) is a ginseng ( Panax ) belonging to the Araliaceae ginseng CA MEYER ) dry roots. Red ginseng is steamed and dried ginseng, taste is sweet and slightly bitter, the nature is flat, and it enters the nasal cavity and lungs. It is mainly used in oriental medicine, and it is mainly used for sedation and excitement of the central nervous system. It has the effect of preventing hypertension or atherosclerosis, so it acts as a strong heart, antioxidant, anti-fatigue, anti-radioactive and hypoglycemic. The main ingredients are saponin (ginsenosides), panaxynol, beta-elemene and maltol. Liquid extracts of red ginseng have been used to treat anemia, diabetes, insomnia, gastritis, blood pressure disorders, indigestion, overwork, and fatigue.

The wolfberry included in the composition of the present invention Lycium wolfberry belonging to the family Solanaceae chinense Mill. Or other mature fruit of the same plant, mainly contains carotene, vitamin B1, vitamin B2, nicotin acid, vitamin C, β-sitosterol, linoleic acid and the like. According to the oriental medicine, the properties are flat, the taste is sweet, and it enters the liver and kidneys to enhance the function, supplement the tablets, and clear the eyes. Consistently taking it will reduce cholesterol and help prevent atherosclerosis. Its roots can also be used as a medicine, and pharmacological experiments of the root bark have shown that there is a drop in blood pressure, lowering blood sugar, and bactericidal action.

The cornus in the composition of the present invention is dried mature fruit of the cornus tree, which is a deciduous arborescent belonging to the dogwood (山茶 ： 科 ： Cornaceae ), the flesh of cornin, that is, verbenalin, saponin, tannin, ursolic acid and vitamin A The seed oil contains palmitin acid, olein acid and linol acid. Cornine, a potent ingredient in the stomach, boosts metabolism and contains anti-diabetic substances. Recent studies have reported that cornus milk boosts the activity of immune cells, boosts immune function, and has some degree of anti-cancer effect. In oriental medicine, the properties are warm, the taste is sour or steamed, and it acts on the liver and kidneys. Replenishes the function of the liver, kidneys and catches semen outflow.

Schisandra chinensis is included in the composition of the present invention belong to the Schisandra schisandraceae (Schisandraceae) (North Schisandra) Schisandra chinensis Baill. Or Schisandra chinensis ( South Schisandra chinensis) S. sphenanthera Rehd . et Wils.'s ripe fruits are dried, containing about 3% essential oils, and various sesquicarene, β2-bisabclene, β-chamigrene, and α-ylangene. The dried fruit contains 12% citral, 10% malic acid, and a small amount of tartaric acid, in addition to fructose, resin and the like. The nature is warm, flavored and sweet. It enters the lungs, heart and kidneys, converges and recollects, replenishes and produces essences, replenishes the energy of the kidneys and produces essences.

Bokbunja contained in the composition of the present invention refers to less ripe fruit, that is, immature fruit of Rubus coreanus, a deciduous shrub of the Rosaceae family. Bokbunja has not only been used for food, but also as a medicinal herb for renal function, infertility, erosion, well-ventilation and jeongjeongje in oriental medicine and folk medicine. Bokbunja are known to have interpolation, nominal and diuretic effects. It was confirmed that the stem of Rubus Koreanum contained tannin components (-)-epicatechin, (+)-catechin and proanthocyanidins, and various flavonoid compounds were contained in the leaves.

Tosaja included in the compositions of the present invention (兎絲子, Cuscuta japonica Choisy ) is a year-round grass with vines growing, Cuscuta japonica Choisy ), C. australis R. and C. chinensis Lam . Tosa is known for its efficacy as a hardening and tonic agent, including resin glycosides, vitamin A, and β-carotene-5, 6-epoxide, taraxanthin and lutein. And the like.

Curcuma ( Curcuma aromatica Salisb. ) Included in the composition of the present invention is a perennial ripening herbaceous plant, which is a turmeric root, turmeric, turmeric, and buds. Antibiotic metabolism affects lipid metabolism (animal testing), which can reduce the formation of endothelial masses in the main and coronary arteries, reduce the deposition of lipids, and contain essential oils that promote bile secretion and excretion. It is known to be used for cholelithiasis because it has a dipharytic effect by contracting the gallbladder and dissolves filamentous stones. In addition, according to the Chinese herbal medicine dictionary, the taste is spicy and bitter, and the nature is limited and nontoxic, and it promotes the circulation of the qi, loosening the loose, bleeding blood and removing the blood. It is known to treat thorax abdominal pain, vaginal embolism, fever newlyweds, hemorrhage, nasal bleeding, hematuria, hemorrhage, menstruation of men and jaundice.

Angelica included in the compositions of the present invention is a perennial plant belonging to the Apiaceae (Umbelliferae) Angelica Angelica gigas Angelica gigas Nakai's roots are dried. Consists of essential oils and decousins, sedating beta sitosterol, sucrose, nicotinic acid and folic acid. Various women's diseases, menstrual disorders, menstrual cramps, anemia, poor uterine development, postpartum blood deficiency, menopausal disorders, etc. are effective throughout the female hormone secretion is effective. Recent studies have shown that donkeys have an excellent effect on cellular immune responses. In oriental medicine, it is warm in nature, sweet in taste, and works in the heart, liver and spleen. It replenishes and harmonizes the blood, regulates menstruation (menstruation), and helps stool well.

Each herbal material included in the composition of the present invention may be used without limitation, such as cultivated or commercially available, and can be extracted or used as it is in a dry or natural state.

The herbal extracts of the present invention can be prepared using conventional methods known in the art, i.e., under conventional conditions of temperature and pressure, using conventional solvents. Extractive solvents that may be used to prepare the herbal extracts of the present invention include, for example, water, lower alcohols having 1 to 4 carbon atoms, acetone, ether, ethyl acetate, butyl acetate, chloroform, methylene chloride, hexane and 1,3 butylene Extraction solvents, such as glycol, may be used alone or in combination, preferably methanol or ethanol, but is not limited thereto. A suitable amount of the extraction solvent is about 1 to 20 times the dry weight of the herbal medicine, preferably 2 to 10 times. In addition, as the extraction method, heat extraction, cold needle extraction, reflux cooling extraction, ultrasonic extraction, and the like may be used, and may be used by repeatedly extracting one or several times. In addition, the extraction temperature and extraction time is not particularly limited as long as the temperature and time such that the effective activity of the useful ingredient of each herbal medicine is not removed.

In addition, the herbal extract of the present invention can be used by purification through a conventional purification process. For example, various purification methods additionally performed, such as separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through can be used. In addition, the herbal extract of the present invention can be prepared and used in a powder state through a drying process such as distillation under reduced pressure, freeze drying and spray drying.

The pharmaceutical composition comprising the herbal extract of the present invention has antioxidant activity and exhibits anticancer effect on liver cancer. The composition is characterized by containing a large amount of phenolic compound. Phenolic compounds are one of the secondary metabolites widely distributed in the plant system and have various structures and molecular weights, and flavonoids and tannins are the main components. Flavonoids are aromatic polyphenols and are broadly classified into flavonols, flavones, flavanones, flavanones, flavanols, anthocyanidins and isoflavones. . Because they have phenol hydroxyl (OH) groups, they easily bind to proteins and other macromolecules and have various physiological activities such as antioxidants and anticancer. Therefore, as the content of phenolic compound increases, antioxidant activity is enhanced.

In addition, the herbal extract of the present invention exhibits anticancer activity against liver cancer by inhibiting hepatocyte damage caused by oxidative stress. In a specific embodiment of the present invention, the pharmaceutical composition of the present invention can be confirmed to inhibit the hepatocyte damage by DEN (diethylnitrosamine) known as a carcinogen causing long-term damage by oxidative stress.

The composition of the present invention may further include various other types of herbal extracts for enhancing the pharmacological anticancer effect of the herbal extracts, in addition to the herbal extracts of the red ginseng, goji berry, cornus oil, Schisandra chinensis, bokbunja, earth and sand, turmeric, and Angelica as active ingredients. have. Herbal extracts that may be additionally included in the composition of the present invention include pharmaceutically acceptable herbal medicines, including Gobon, Cheonma, Shiho, Doin, Gyeji, Rhubarb, Licorice, Cheongung, Dermis, Taxa, Hulk, Golden, Bokyeong, Peony, Baekchul, Hwangbaek, Gardenia, Banja, Morning Light, Jisil, Ginseng, Macmun-dong, Wonji, Seokchangpo, Creation, Gamkook, Windproof, Ginger, Forget-me-not, Contrast, Sweet Ginseng, Barberry, Chihwang, Mint, Mountain Fertilizer, Spirit, Shou, Guja, Absolute, Poisonous life, tofu, baekryeoksaengcho, three hundred seconds, jinjin, jimo, safflower, Astragalus, calendula, ginkgo biloba, hwangjeong, lotus root, keel, phalanges, dew, sagejiku, black sesame, white porcelain, malt, pageokcheon and seaweed are available. The herbal extracts may be used alone or in combination. In this case, the 'pharmaceutically acceptable' refers to a physiologically acceptable and, when administered to an organism, usually does not cause an allergic reaction or the like.

The pharmaceutical composition of the present invention may further comprise a pharmaceutically acceptable carrier, and may be formulated with the carrier. In this case, the 'pharmaceutically acceptable carrier' refers to a carrier or diluent that does not stimulate an organism and does not inhibit the biological activity and properties of the administered substance.

The composition may be prepared by filling the herbal extract with no excipient in the capsule or uniformly and sufficiently in contact with the atomized solid carrier, liquid carrier or both, and, if necessary, the product may be molded into a desired formulation. Examples of suitable carrier excipients include starch, water, saline, ethanol, glycerol, Ringer's solution and dextrose solution, and the like (Remington's Pharmaceutical Science, 19 ^th Ed., 1995, Mack Publishing Company, Easton PA) and the like. As disclosed, it may be formulated into a suitable formulation known in the art.

In addition, the pharmaceutical composition of the present invention can be applied to any formulation containing it as an active ingredient, it can be prepared in oral or parenteral formulations. Pharmaceutical formulations of the invention may be oral, rectal, nasal, topical (including the cheek and sublingual), subcutaneous, vaginal or parenteral (intramuscular, subcutaneous). And forms suitable for administration by inhalation or insufflation.

Oral dosage forms containing the composition of the present invention as an active ingredient include, for example, tablets, troches, lozenges, water-soluble or oily suspensions, preparation powders or granules, emulsions, hard or soft capsules, syrups or elixirs. can do. For formulation into tablets and capsules, lactose, saccharose, sorbitol, mannitol, starch, amylopectin, binders such as cellulose or gelatin, excipients such as dicalcium phosphate, disintegrants such as corn starch or sweet potato starch, stearic acid masne It may include a lubricating oil such as calcium, calcium stearate, sodium stearyl fumarate or polyethylene glycol wax, and in the case of a capsule, it may further contain a liquid carrier such as fatty oil in addition to the above-mentioned materials.

Formulations for parenteral administration comprising the composition of the present invention as an active ingredient include injectables, creams, lotions, external ointments, oils, moisturizers, gels, aerosols and nasal inhalants in the form known in the art. Can be mad. Specifically, it may be formulated for injection such as subcutaneous injection, intravenous injection or intramuscular injection, suppository injection method or aerosol for inhalation through respiratory system. To formulate injectable formulations, the compositions of the present invention may be mixed in water with stabilizers or buffers to prepare solutions or suspensions, which may be formulated for unit administration of ampoules or vials. For infusion into suppositories, it may be formulated as a rectal composition such as suppositories or body enema including conventional suppository bases such as cocoa butter or other glycerides. When formulated for spraying such as aerosols, a propellant or the like may be combined with the additives to disperse the dispersed dispersion or wet powder.

The pharmaceutical composition of the present invention comprises arithmetic and Angelica known as the main constituents of the resonant stage, which is a representative herbal medicine, and contains other herbal medicines, that is, red ginseng, wolfberry, Schisandra chinensis, bokbunja, earthenware and turmeric in an appropriate amount, Since it exhibits anti-cancer activity, it can be used to manufacture anti-cancer resonators for preventing or treating liver cancer. Therefore, the composition of the present invention is particularly preferably processed in the form of pills. The pill form is concentrated by extracting the herbal medicine and then finely pulverizing each medicine by using a grinder to mix the extract and powder, and put the powder mixed with the chemical liquid again into a grinder to filter the fine particles 300-500mesh sieve fine particles Can be made with honey or hwan (dan) or dan (元), yuan (yuan) and the like. Herbs made of round, sweet and round can be packaged again using edible gold leaf (or silver leaf). Gold or silver has long been used in making pills to stabilize the mind and have been used as an auxiliary material in prescriptions such as resonant stages and cow sulfur cheongsimwon with the effect of insect repellent protection. In addition, the process of making the ring in the other form is the same, and has been used as a dye from herbal medicines such as porcelain and salvia and has been used as a dye from the past, and can be used by coating the surface to extract the effective insect repellent.

The method for preventing or treating liver cancer of the present invention is characterized by comprising administering the pharmaceutical composition.

As used herein, the term "administration" means introducing a pharmaceutical composition of the present invention to a patient in any suitable manner, and the route of administration of the composition of the present invention may be various oral or parenteral routes as long as it can reach the desired tissue. It may be administered through, or specifically, can be administered in a conventional manner via oral, rectal, topical, intravenous, intraperitoneal, intramuscular, intraarterial, transdermal, nasal, inhalation, intraocular or intradermal route. . Preferably oral administration.

The treatment method of the present invention comprises administering a composition containing the herbal extract in a pharmaceutically effective amount. It will be apparent to those skilled in the art that a suitable total daily dose may be determined by the practitioner within the correct medical judgment and may be administered to the patient in a single dose and in multiple doses. Administration may be by long-term, fractionated treatment protocols. The specific therapeutically effective amount for a particular patient may be based on the specific composition, including the type and severity of the reaction to be achieved, whether or not other agents are used in some cases, the age, weight, general health, sex and diet of the patient, time of administration, It is desirable to apply differently depending on the route of administration and the rate of release of the composition, the duration of treatment, and the various factors and similar factors well known in the medical arts, including drugs used with or concurrent with the specific composition. Therefore, the effective amount of a pharmaceutical composition suitable for the purpose of the present invention is preferably determined in consideration of the above matters. However, for the desired effect, the compound of the present invention may be administered in an amount of 0.0001 to 100 mg / kg, preferably 0.01 to 10 mg / kg, divided once or several times daily.

In addition, the method for preventing or treating liver cancer of the present invention is applicable to any animal in which liver cancer may occur, and animals include humans and primates, as well as domestic animals such as cattle, pigs, sheep, horses, dogs, and cats. .

In addition, the composition of the present invention can be used alone or in combination with methods using surgery, hormonal therapy, drug therapy and biological response modifiers for the treatment of liver cancer.

The composition comprising the extract of the red ginseng, goji berry, cornus milk, Schisandra chinensis, bokbunja, earth and sand, turmeric and Angelica as an active ingredient can be used as a health functional food composition for preventing or improving liver cancer.

The composition of the present invention may be added to a dietary supplement for the purpose of preventing or improving liver cancer. In this case, each herbal material included in the composition may be used in a manner of additionally adding the powder itself in addition to the extract form.

The health functional food may be prepared by adding other food materials according to the commerciality and consumer preference of the final product. The effective amount of the composition can be suitably determined according to the purpose of use (prevention, health or therapeutic treatment), preferably 0.001 to 90% by weight, more preferably 5 to 5, based on the dry weight of the herbal medicine relative to the total raw material. It can be added at 30% by weight.

The pharmaceutical composition of the present invention can be prepared as a health functional food in the form of a preparation by further comprising a food additive acceptable food formulation, the form of the preparation can be tablets, capsules, pills, liquids and the like. .

In addition, there is no particular limitation on the kind of food to which the composition can be added. For example, beverages (including alcoholic beverages), fruits and processed foods (e.g. canned fruit, canned foods, jams, marmalade, etc.), fish, meat and processed foods (e.g. ham, sausage cornebi, etc.) , Breads and noodles (e.g. udon, soba, ramen, spaghetti, macaroni, etc.), fruit juices, various drinks, cookies, malts, dairy products (e.g. butter, cheese, etc.), edible vegetable oils, margarine, vegetable protein, retort food , Frozen foods, various seasonings (e.g., miso, soy sauce, sauce, etc.) are possible, and includes all functional foods in the usual sense.

In addition, the health functional food of the present invention is a variety of flavors, natural carbohydrates, sweeteners, vitamins, electrolytes, colorants, pectic acid, alginic acid, organic acids, protective colloidal thickeners, pH regulators, stabilizers, preservatives, glycerin, alcohols, carbonating agents And the like may be further contained. In particular, the natural carbohydrate may be a sugar such as glucose, monosaccharides such as fructose, maltose, disaccharides such as sucrose, polysaccharides such as dextrin, cyclodextrin, xylitol, sorbitol, and erythritol. As a sweetener, natural sweeteners such as tautin and stevia extract, synthetic sweeteners such as saccharin, aspartame, and the like can be used. The ratio of such additives is not critical but may be selected in the range of 0.01 to 10 g per 100 ml of the composition of the present invention.

[ Example ]

Hereinafter, the configuration and operation of the present invention through the preferred embodiment of the present invention will be described in more detail. However, the following examples are provided to aid understanding of the present invention, and the scope of the present invention is not limited to the following examples. Details that are not described herein will be omitted since those skilled in the art can sufficiently infer technically.

Example  1. Material Preparation

<1-1> Medicinal Herb Extract

As a material contained in the composition of the present invention, red ginseng, wolfberry, cornus oil, Schisandra chinensis, bokbunja, earth and sand, turmeric and Angelica were purchased and then ground. The powdered herbal medicines were made to have a total herbal weight of 1 kg in the composition of Table 1, and then extracted with 4 L of 100% methanol for 4 hours at 70 ° C. using an extractor to prepare a herbal extract.

Medicinal name ratio(%) Red ginseng 20 Wolfberry 20 Cornus 10 Schisandra 10 Bokbunja 10 Tosa 10 Turmeric 10 Donkey 10 system 100

<1-2> herbal extract fraction preparation

The 100% methanol extract prepared in the above <1-1> process was prepared in five fractions by separating the non-polar solvent from the polar solvent in the order of polar solvent using the polarity difference of the solvent in the same manner as in FIG. 1. In other words, the methanol extract was concentrated under reduced pressure, n-hexane and water were mixed and dissolved in the separatory funnel to obtain an n-hexane fraction layer. Thereafter, the aqueous layer was placed in a separatory funnel, and chloroform, ethyl acetate, n-butanol and aqueous fractions were sequentially obtained in the same manner. The methanol extract, the hexane fraction, the chloroform fraction, the ethyl acetate fraction, the butanol fraction, and the extract of the aqueous layer were then concentrated under reduced pressure, lyophilized, and the yield of each fraction was determined by gravimetric method. Each fraction extract was stored frozen at -70 ℃ was used in the experiment. The herbal extract thus obtained was named 'anticancer diagnostic diagnosis extract'.

<1-3> Preparation of experimental animals

Age rats (Rat, Sprague Dawley) of about 180 ± 10 g body weight were purchased from Samtako (Osan, Korea). The experimental animals were supplied with sufficient solid food (for samtaco, rats) and water under certain conditions (temperature: 21 ± 2 ℃, humidity: 50-60%, 12 hours light / dark cycle) in the animal breeding room of Wonkwang University. Adapted for 1 week while being used in the experiment.

All animal experiments were performed according to a protocol approved by Wonkwang University Animal Care Committee.

Example  2. Antioxidant Activity of Herbal Extracts

The formation and development of cancer by oxidative stress is well known. In addition, the main mechanism of DEN stimulation, a carcinogen, is in inducing oxidative stress. Therefore, the present inventors confirmed the degree of oxidative stress inhibition to determine whether the herbal extracts can inhibit oxidative stress.

<2-1> ABST radical scavenging ability measurement

ABST method is the most frequently used method of indirect one of the antioxidant capacity measurement method. Antioxidant activity was measured using ABTS radicals by removing the ABTS free radicals produced by the reaction with potassium persulfate by the antioxidants in the sample and decolorizing the cyan color which is specific to radicals. Measured. Specifically, 7 mM 2.2-azino-bis (3-rthylbenzthiazoline-6-sulfonic acid) (ABTS) and 2.45 mM potassium persulfate were mixed at the final concentration for 24 hours in a cow at room temperature to form ABTS + radical at 732 nm. Diluted with distilled water so that the absorbance value is 0.9 (± 0.1). 50 µl (10 mg / ml concentration) of crude extracts (methanol extract, chloroform fraction, ethanol fraction and hexane fraction) of each fraction was added to 950 µl of diluted ABTS radical solution and measured after 10 minutes to change the absorbance after mixing. Equivalent amount of Trolox was added. ABST scavenging ability was calculated by the method of Equation 1 below, the results are shown in FIG.

[Equation 1]

ABTS scavenging ability (%) = 1- (Sample absorbance / untreated absorbance) × 100

As shown in Figure 2, the ABST antioxidant activity of the methanol extract was observed to be about 81.17 ± 0.36%, the chloroform fraction showed an antioxidant capacity of 72.40 ± 0.24%. Ethyl acetate fraction showed the lowest ABST antioxidant activity of about 65.13 ± 0.14%, and n-hexan fraction showed the highest ABST antioxidant activity of 92.68 ± 0.24%. These results suggest that the herbal extract (anticancer diagnostic diagnostic extract) of the present invention contains a large amount of a natural water-soluble phenolic substance, and in particular, it is estimated that the most natural water-soluble phenolic substance is contained in the n-hexan fraction layer. can do.

<2-2> Total Phenolic Content Measurement

The total polyphenol content of the herbal extracts was analyzed based on the principle that the Folin-ciacalteu rearent was colored by molybdenum blue as a result of reduction by the polyphenol compound of the anticancer resonance group according to the method of Dewanto10). 100 μl of Folin-Ciocalteau's phenol regent was added to 100 μl of herbal extracts (methanol extract, chloroform fraction, ethanol fraction, and hexane fraction) of each fraction, mixed and allowed to stand at room temperature for 3 minutes, followed by 100 μl of 2% Na ₂ CO ₃ solution. After mixing, the mixture was left at room temperature for 1 hour and the absorbance was measured at 750 nm. In order to compare the extraction efficiency according to the solvent, in Example 1 <1-1>, extracts obtained by extracting the herbal medicine with distilled water instead of methanol were tested together. In order to quantify the total phenol content, gallic acid, a standard substance, was dissolved in distilled water, and prepared according to a constant concentration. Experiments were performed in the same manner as the sample to prepare a calibration curve and to measure the total phenol content of the sample. The results are shown in Table 2 below. It was.

Distilled water MeOH CHCl ₄ EtoAc Hexane phenol (1mg / ml) 1.19
± 0.03 1.19
± 0.01 1.05
± 0.008 1.17
± 0.004 1.32
± 0.01 flavonoid (50 mg / ml) 27.87
± 1.23 32.80
± 1.07 30.69
± 0.72 14.09
± 0.54 21.62
± 0.591 The values represent mean ± SE of triplicate independent experiments.

As shown in Table 2, the total phenolic content of the herbal extract was 1.19 ± 0.03 mg / g, the total phenolic content of the methanol extract was observed to be about 1.19 ± 0.01 mg / g. The chloroform fraction showed a total phenolic content of 1.05 ± 0.01 mg / g, the ethyl acetate fraction had a total phenolic content of about 1.17 ± 0.01 mg / g, and the n-hexan fraction was the highest at 1.32 ± 0.01 mg / g. Total phenolic content is shown. The total flavonoid content of the herbal extract was 27.87 ± 1.23 mg / g, and the total flavonoid content of the methanol extract was about 32.80 ± 1.07 mg / g. The chloroform fraction showed a total phenolic content of 30.69 ± 0.72 mg / g, the ethyl acetate fraction had a total flavonoid content of about 14.09 ± 0.54 mg / g, and the n-hexan fraction had a total flavonoid of 21.62 ± 0.59 mg / g. Content is indicated.

<2-3> Determination of Superoxide dismutase (SOD) -like activity

SOD is known as an enzyme that can suppress aging by reducing superoxide to normal oxygen and various diseases such as cancer involving superoxide. In the SOD-like activity, pyrogallol is automatically oxidized by superoxide radicals in water to form a brown substance, which is analyzed by spectrophotometer, and the oxidation rate of pyrogallol is lowered when a substance having superoxide trapping activity is present. Superoxide capture activity can be measured indirectly. SOD-like activity was measured according to Markund et al. 2.6 ml of herbal extracts (methanol extract, chloroform fraction, ethanol fraction and hexane fraction) of each fraction were adjusted to pH 8.5 with 2.6 ml of Tris-HCl buffer (50 mM tris amino-methane and 10 mM EDTA) and 7.2 After 0.2 ml of mM pyrogallol was added and reacted at 25 ° C. for 20 minutes, 0.1 ml of 1N HCl was added to stop the reaction. The amount of oxidized pyrogallol in the reaction solution was measured for absorbance at 420 nm. SOD-like activity measurement was calculated by the following equation 2, the results are shown in FIG.

[Equation 2]

SOD-like activity (%) = {1- (Sample Absorbance / Untreated Absorbance)} × 100

As shown in Figure 3, the SOD-like activity of the methanol extract was observed to be about 20.93 ± 0.91%, the chloroform fraction showed a SOD-like activity of 7.67 ± 0.31%. Ethyl acetate fraction showed SOD-like activity at 26.52 ± 0.61% and n-hexan fraction showed SOD-like activity at 26.52 ± 3.15%.

These results indicate that the SOD-like activity of the herbal extracts is relatively high, especially the SOD-like activity of the ethyl acetate layer and the n-hexan layer is high. However, the chloroform fractionation layer was found to be slightly degraded SOD-like activity.

Example  3. Herbal Extracts Induced Liver Cancer Rat  Assessment of impact on liver tissue

The herbal extracts were stimulated with DEN in the rat prepared in Example 1 <1-3> to induce liver cancer, and then examined the effects on liver tissue.

Specifically, induction of liver cancer was performed as follows. The experimental group was divided into three groups of five by the ingot method, divided into normal group (group I), control group (DEN injection, group II), and dietary intake experimental group (DEN + anticancer diagnostic methanol extract, group III). After preliminary breeding for 1 week, the control group was administered with 150 ppm of DEN in negative form for 12 weeks. The experimental group (group III) dissolved the normal feed and ethanol extract of anticancer diagnostic diagnostics of 150ppm + 100 mg / kg of DEN and supplied it with negative water.

After obtaining whole liver from the five rats of each group, Histology a text and Atlas. Michael H. Ross, Wojciech Pawlina. Kim Jin-jung and five others. Color histology walk. The shape of liver tissue was examined by referring to the method described in [Korea Medicine]. Specifically, the obtained liver tissue was fixed with NBF solution, and then, paraffin embedding was performed to prepare tissue sections of 5 μm thickness using a microtome, and then hematoxylin & eosin (HE) staining was performed. After observing the cell morphology of liver tissue under a microscope using a specimen having more than 100 fields (micrometers), the results are shown in FIG.

As shown in FIG. 4, the extracted liver tissues were observed under an optical microscope, and the liver tissues of the normal group (Group I) had distinct round nuclei, and the cytoplasm was uniformly stained with eosin. have.

The liver tissue of the control group (Group II), which induced liver cancer with NDEN, has a less uniform structure of hepatic lobules than the normal group (Group I) and the experimental group (Group III). It is more formed than I) and experimental group (Group III). For reference, Mourao et al., Yoon J.S. In the study of NDEN-induced liver cancer, the most prominent feature of liver injury in the NDEN-only group was the increase in hepatocellular swelling, cytoplasmic fear, and fear formation compared to the normal control group. Consistent with the results.

The cells shown in the blue circle of the control group (Group II) taken at 400 times were found to have a specific type of cells not seen in the normal group (Group I) and the experimental group (Group III). In the experimental group fed the resonant stage (Group III), the structure of hepatic lobe was relatively well maintained, and the nucleus shape was relatively clear. Almost no cytophobia was observed in the experimental group (Group III), and no specific cell types were observed as in the control group (Group II).

Example  4. Herbal Extracts Induced Liver Cancer Rat  In serum LDH , AST , ALT , ALP  Assessment of impact on activity

The herbal extract stimulates rats prepared in Example 1 <1-3> with DEN to cause liver cancer, and then lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and alkaline (ALP) in serum. phosphatase) activity was evaluated.

LDH is a nonspecific marker, which is used mainly to estimate the presence of malignant tumors because the concentration of blood increases during cell destruction of organs.

AST and ALT are specific enzymes in cardiomyocytes and hepatocytes, and the activity in serum is increased by damage to tissue cells. This increase in activity occurs in hepatobiliary disease and heart disease, especially in chronic hepatitis.

ALP can be elevated in chronic hepatitis and cirrhosis, but it is known that bile produced is significantly increased when bile is not well excreted from liver cells or blocked.

First, liver cancer induction was performed in the same manner as in Example 3 above. The experimental group was divided into three groups of five by the ingot method. After preliminary breeding for 1 week, the control group was administered with 150 ppm of DEN in negative form for 12 weeks. The diet intake group (group III) dissolved conventional feed and DEN 150ppm + 100 mg / kg GJD and supplied it as a negative water.

After 12 weeks of drug administration, rats were anesthetized with urethane, and then dissected along the midline of the abdomen and ascended intravenous bleeding. The blood was placed in a test tube and allowed to stand at room temperature for 30 minutes to coagulate the blood, and then centrifuged at 3000 rpm, and the supernatant was collected and stored in a -80 ° C. cryogenic freezer for use in experiments.

<4-1> LDH activity impact measurement

The serum obtained from the above was measured for LDH activity, and LDH activity was measured using a kit reagent for autoanalyzer (Dong-Pharma), and the results are shown in FIG. 5.

As a result, as shown in Fig. 5, the LDH activity was significantly increased in the control group compared to the normal group, and in the experimental group coadministered with the herbal extracts, a significant decrease compared to the control group was observed.

<4-2> Measuring the Effect of AST and ALT Activity

AST and ALT activity was measured in the serum obtained above, AST and ALT activity was measured using a kit reagent for autoanalyzer (Dong-Pharma), and the results are shown in FIGS. 6 and 7.

As a result, as shown in Figures 6 and 7, AST and ALT activity was observed to be significantly increased in the control group compared to the normal group, and in the experimental group coadministered with the herbal extract was observed to be significantly reduced compared to the control group .

<4-3> ALP activity impact measurement

Serum obtained above was measured for ALP activity, and ALP activity was measured using an automatic analyzer kit reagent (Dynamic Pharmaceuticals), and the results are shown in FIG. 8.

As a result, as shown in Figure 8, the ALP activity was observed to be increased in the control group compared to the normal group, in the experimental group coadministered with the herbal extract was observed to be significantly reduced compared to the control group.

Therefore, it is confirmed that the herbal extract of the present invention significantly inhibits hepatocyte damage in a model of inducing liver cancer due to oxidative stress.

Claims (6)

Pharmaceutical composition for liver cancer prevention or treatment comprising red ginseng, wolfberry, cornus, Schisandra chinensis, bokbunja, earthenware, turmeric and Angelica extract as an active ingredient. The method of claim 1,
The composition is characterized in that it has an antioxidant activity, liver cancer preventive or therapeutic pharmaceutical composition. The method of claim 1,
The composition is characterized in that for the production of anti-cancer resonance stage, liver cancer prevention or treatment pharmaceutical composition. The method of claim 1,
The extract is characterized in that extracted from water, lower alcohol having 1 to 4 carbon atoms, acetone, ether, ethyl acetate, butyl acetate, chloroform, methylene chloride, hexane, 1,3 butylene glycol or a mixed solvent thereof, liver cancer Prophylactic or therapeutic pharmaceutical compositions. The method of claim 1,
The composition is Gobon, Cheonma, Shiho, Doin, Gyeji, Rhubarb, Licorice, Cheongung, Dermis, Taxa, Huanglian, Golden, Fuling, Peony, Baekchul, Hwangbaek, Gardenia, Banja, Jogu etc., Jisil, Ginseng, Macmundong, Wonji, Seokchangpo , Creation, gamguguk, windproof, ginger, forget-me-not, contrast, dansam, bark, shihwang, peppermint, pesticide, ghost, sewao, guja, faultless, poisonous, tofu, baekhwasacho, three hundred seconds, injin, jimo, safflower Ginkgo biloba, hwangjeong, lotus root, keel, phalanges, pulp, ulji sulphate, black sesame, white porcelain, malt, pagokcheon and Haesong, characterized in that it further comprises one or more herbal extracts, liver cancer prevention or treatment pharmaceutical Composition. Red ginseng, wolfberry, cornus, Schisandra chinensis, bokbunja, earthenware, turmeric and Angelica extract containing the extract as an active ingredient for liver cancer prevention or improvement health functional food composition.

Images